AstraZeneca acquires Omniose, to bolster it's preclinical infectious disease programs.
Feature|Articles|August 20, 2026
How to Rebuild Pharma Operating Model for an AI Era
In pharma's AI transformation, the technology was never the hard part — fixing the operating model that has to act on what AI surfaces is.
Advertisement
Advertisement
In the early 2000s, AstraZeneca’s gefitinib program in lung cancer was widely viewed as disappointing based on overall trial results. Yet buried within the data was a striking signal: a subgroup of patients experienced dramatic tumor responses—patients later shown to carry EGFR mutations. The finding became a landmark in biomarker-driven oncology, proving that the right therapy can look ineffective in the average patient while being transformative for the right subgroup.
Related to this article
As AI accelerates drug discovery, the industry’s next challenge is building a connected, standards-based data infrastructure capable of supporting it through clinical development.
AI can make clinical trials smarter and faster, but lived patient experience remains irreplaceable in guiding research toward optimal results.
FDA is requiring manufacturers of all GLP-1 receptor agonists to add a warning for a potential increased risk of NAION.
AI can make clinical trials smarter and faster, but lived patient experience remains irreplaceable in guiding research toward optimal results.
argenx acquires Unnatural Products, adding a macrocyclic peptide discovery platform to complement its antibody engineering.
The termination ends a cardiometabolic RNA-editing partnership that was paused for 12 months, closing out a deal under which Korro earned no milestone payments.
ANI Pharmaceuticals makes an offer to acquire Egetis Therapeutics as Egetis separately sells its priority review voucher for $190 million, Novartis exits its BrainTransporter deal with BioArctic 14 months after signing, and Ignite Proteomics’ Dr. Brian Corgiat on improving how tumors are tested after recurrence.
Advertisement
Advertisement